Yüklüyor......
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias
BCR-ABL-mediated leukemias, either Chronic Myeloid Leukemia (CML) or Philadelphia positive Acute Lymphoblastic Leukemia (ALL), are the paradigm of targeted molecular therapy of cancer due to the impressive clinical responses obtained with BCR-ABL specific tyrosine kinase inhibitors (TKIs). However,...
Kaydedildi:
| Yayımlandı: | Adv Hematol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi Publishing Corporation
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4710905/ https://ncbi.nlm.nih.gov/pubmed/26843864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/612567 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|